PTK2 and cancer: OVOS2 silencing reduced the expression of key cancer related signal markers p-FAK, p-AKT, and p-ERK, without affecting the expression of AKT, ERK, and FAK in A375 cells, indicating a possible role of OVOS2 in activating these pathways.